BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30766527)

  • 1. Linezolid in Combination With Azoles Induced Synergistic Effects Against
    Lu M; Yang X; Yu C; Gong Y; Yuan L; Hao L; Sun S
    Front Microbiol; 2018; 9():3142. PubMed ID: 30766527
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline and Fluconazole Have a Synergistic Effect Against
    Kong Q; Cao Z; Lv N; Zhang H; Liu Y; Hu L; Li J
    Front Microbiol; 2020; 11():836. PubMed ID: 32431685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans.
    Lu M; Yan H; Yu C; Yuan L; Sun S
    Sci Rep; 2020 Jan; 10(1):498. PubMed ID: 31949170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic potential of teriflunomide with fluconazole against resistant
    Li X; Kong B; Sun Y; Sun F; Yang H; Zheng S
    Front Cell Infect Microbiol; 2023; 13():1282320. PubMed ID: 38169891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin synergises with azoles against drug-resistant Candida albicans.
    Lu M; Yu C; Cui X; Shi J; Yuan L; Sun S
    Int J Antimicrob Agents; 2018 Jan; 51(1):107-114. PubMed ID: 28943366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination With Fluconazole Against
    Gong Y; Liu W; Huang X; Hao L; Li Y; Sun S
    Front Microbiol; 2019; 10():1461. PubMed ID: 31312187
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant
    Li X; Wu X; Gao Y; Hao L
    Front Microbiol; 2019; 10():2295. PubMed ID: 31749766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Synergistic Antifungal Effect and Potential Mechanism of D-Penicillamine Combined With Fluconazole Against
    Li Y; Jiao P; Li Y; Gong Y; Chen X; Sun S
    Front Microbiol; 2019; 10():2853. PubMed ID: 31921035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
    Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
    Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal Activity and Potential Mechanism of Panobinostat in Combination With Fluconazole Against
    Su S; Shi X; Xu W; Li Y; Chen X; Jia S; Sun S
    Front Microbiol; 2020; 11():1584. PubMed ID: 32765454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS; Malik A; Ahmad I
    Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo.
    Li X; Yang H; Duan X; Cui M; Xing W; Zheng S
    Expert Rev Anti Infect Ther; 2023; 21(11):1259-1267. PubMed ID: 37818633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.
    Gu W; Guo D; Zhang L; Xu D; Sun S
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6179-88. PubMed ID: 27503639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant
    Tan J; Jiang S; Tan L; Shi H; Yang L; Sun Y; Wang X
    Front Microbiol; 2021; 12():649026. PubMed ID: 34054751
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.